Copyright
©The Author(s) 2021.
World J Clin Cases. Nov 26, 2021; 9(33): 10143-10150
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10143
Published online Nov 26, 2021. doi: 10.12998/wjcc.v9.i33.10143
Groups | n | MACE, n | Incidence of MACE, % | Hc value | P value |
GRACE scores (points) | 7.398 | 0.031 | |||
Low risk group (0-88) | 95 | 13 | 13.7 | ||
Intermediate risk group (89-117) | 151 | 48 | 31.7 | ||
High risk group (≥ 118) | 140 | 47 | 33.6 | ||
SYNTAX scores (points) | 4.381 | 0.042 | |||
Low risk group (0-22) | 330 | 85 | 25.8 | ||
Intermediate risk group (23-32) | 42 | 17 | 40.5 | ||
High risk group (≥ 33) | 14 | 6 | 42.9 | ||
Treatment | 8.123 | 0.021 | |||
Medication group | 195 | 36 | 18.5 | ||
Stent group | 156 | 57 | 36.5 | ||
CABG group | 35 | 15 | 42.9 | ||
Total | 386 | 108 | 28.0 |
- Citation: Wang XF, Zhao M, Liu F, Sun GR. Value of GRACE and SYNTAX scores for predicting the prognosis of patients with non-ST elevation acute coronary syndrome. World J Clin Cases 2021; 9(33): 10143-10150
- URL: https://www.wjgnet.com/2307-8960/full/v9/i33/10143.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i33.10143